Lead Product(s): Azelaic Acid
Therapeutic Area: Dermatology Product Name: Undisclosed
Highest Development Status: Approved Product Type: Small molecule
Partner/Sponsor/Collaborator: Leo Pharma
Deal Size: Undisclosed Upfront Cash: Undisclosed
Deal Type: Licensing Agreement April 02, 2020
Foamix Pharmaceuticals has entered into a settlement and license agreement to resolve the remaining pending patent litigation involving Finacea® Foam.